Baclofen in the Treatment of Spasticity

Authors
Category Primary study
JournalBMJ
Year 1971
Baclofendagger (Lioresal), a derivative of gamma-aminobutyric acid, was introduced in 1966 as a possible treatment for spasticity due to corticospinal tract lesions. Preliminary studies suggested that it may be more effective than other spasmolytic agents currently available, and a double-blind controlled trial in a group of 23 patients against placebo has shown it to be significantly more effective.
Epistemonikos ID: ef90a4ff41810cdea26cbd9548252185b9c0ad1c
First added on: Jul 17, 2017